125 related articles for article (PubMed ID: 38775483)
21. Establishment of an AUC
Chavada R; Ghosh N; Sandaradura I; Maley M; Van Hal SJ
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28242672
[TBL] [Abstract][Full Text] [Related]
22. The Safety and Efficacy of AUC/MIC-Guided vs Trough-Guided Vancomycin Monitoring Among Veterans.
Folkers A; Anderson R; Harris J; Rogen C
Fed Pract; 2023 Jan; 40(1):28-33. PubMed ID: 37223240
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of a trough-only extrapolated area under the curve vancomycin dosing method on clinical outcomes.
Lines J; Burchette J; Kullab SM; Lewis P
Int J Clin Pharm; 2021 Feb; 43(1):263-269. PubMed ID: 32964405
[TBL] [Abstract][Full Text] [Related]
24. Testing the mutant selection window hypothesis with Staphylococcus aureus exposed to daptomycin and vancomycin in an in vitro dynamic model.
Firsov AA; Smirnova MV; Lubenko IY; Vostrov SN; Portnoy YA; Zinner SH
J Antimicrob Chemother; 2006 Dec; 58(6):1185-92. PubMed ID: 17028094
[TBL] [Abstract][Full Text] [Related]
25. Impact of area under the concentration-time curve to minimum inhibitory concentration ratio on vancomycin treatment outcomes in methicillin-resistant Staphylococcus aureus bacteraemia.
Song KH; Kim HB; Kim HS; Lee MJ; Jung Y; Kim G; Hwang JH; Kim NH; Kim M; Kim CJ; Choe PG; Chung JY; Park WB; Kim ES; Park KU; Kim NJ; Kim EC; Oh MD
Int J Antimicrob Agents; 2015 Dec; 46(6):689-95. PubMed ID: 26555059
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetic/pharmacodynamic analysis of teicoplanin in patients with MRSA infections.
Matsumoto K; Watanabe E; Kanazawa N; Fukamizu T; Shigemi A; Yokoyama Y; Ikawa K; Morikawa N; Takeda Y
Clin Pharmacol; 2016; 8():15-8. PubMed ID: 27099534
[TBL] [Abstract][Full Text] [Related]
27. Comparison of single trough-based area under the concentration-time curve versus trough concentration for the incidence of vancomycin-associated nephrotoxicity.
Niwa T; Yasue M; Harada S; Yamada Y; Otsubo M; Yamada M; Matsuoka S; Yamamoto T; Mizusaki Y; Suzuki A
J Infect Chemother; 2022 Jul; 28(7):923-928. PubMed ID: 35379525
[TBL] [Abstract][Full Text] [Related]
28. First-Dose Vancomycin Pharmacokinetics Versus Empiric Dosing on Area-Under-the-Curve Target Attainment in Critically Ill Patients.
Flannery AH; Delozier NL; Effoe SA; Wallace KL; Cook AM; Burgess DS
Pharmacotherapy; 2020 Dec; 40(12):1210-1218. PubMed ID: 33176005
[TBL] [Abstract][Full Text] [Related]
29. Optimal exposure targets for vancomycin in the treatment of neonatal coagulase-negative Staphylococcus infection: A retrospective study based on electronic medical records.
Chen Q; Wan J; Shen W; Lin W; Lin X; Huang Z; Lin M; Chen Y
Pediatr Neonatol; 2022 May; 63(3):247-254. PubMed ID: 35190273
[TBL] [Abstract][Full Text] [Related]
30. Candidates for area under the concentration-time curve (AUC)-guided dosing and risk reduction based on analyses of risk factors associated with nephrotoxicity in vancomycin-treated patients.
Hashimoto N; Kimura T; Hamada Y; Niwa T; Hanai Y; Chuma M; Fujii S; Matsumoto K; Shigemi A; Kawamura H; Takahashi Y; Takesue Y
J Glob Antimicrob Resist; 2021 Dec; 27():12-19. PubMed ID: 34371241
[TBL] [Abstract][Full Text] [Related]
31. Effect modification of dosing strategy (AUC or trough) on AKI associated with vancomycin in combination with piperacillin/tazobactam or cefepime and meropenem.
Mefford B; Wallace KL; Donaldson JC; Bissell Turpin BD; Sen P; Schadler AD; Liu LJ; Thompson Bastin ML
Antimicrob Agents Chemother; 2024 May; 68(5):e0108523. PubMed ID: 38606975
[TBL] [Abstract][Full Text] [Related]
32. Validation of Vancomycin Area under the Concentration-Time Curve Estimation by the Bayesian Approach Using One-Point Samples for Predicting Clinical Outcomes in Patients with Methicillin-Resistant
Ueda T; Takesue Y; Nakajima K; Ichiki K; Ishikawa K; Yamada K; Tsuchida T; Otani N; Takahashi Y; Ishihara M; Takubo S; Ikeuchi H; Uchino M; Kimura T; Matsumoto K; Oda K; Kimura T
Antibiotics (Basel); 2022 Jan; 11(1):. PubMed ID: 35052972
[TBL] [Abstract][Full Text] [Related]
33. The Emperor's New Clothes: PRospective Observational Evaluation of the Association Between Initial VancomycIn Exposure and Failure Rates Among ADult HospitalizEd Patients With Methicillin-resistant Staphylococcus aureus Bloodstream Infections (PROVIDE).
Lodise TP; Rosenkranz SL; Finnemeyer M; Evans S; Sims M; Zervos MJ; Creech CB; Patel PC; Keefer M; Riska P; Silveira FP; Scheetz M; Wunderink RG; Rodriguez M; Schrank J; Bleasdale SC; Schultz S; Barron M; Stapleton A; Wray D; Chambers H; Fowler VG; Holland TL
Clin Infect Dis; 2020 Apr; 70(8):1536-1545. PubMed ID: 31157370
[TBL] [Abstract][Full Text] [Related]
34. Impact of Area Under the Concentration-Time Curve-Guided Monitoring on Vancomycin Nephrotoxicity and Treatment Outcomes in Methicillin-Resistant
Kim YR; Chun HJ; Heo JY; Yoo JS; Choi YH; Kim EJ
Curr Ther Res Clin Exp; 2022; 97():100687. PubMed ID: 36439399
[TBL] [Abstract][Full Text] [Related]
35. Area under the concentration-time curve to minimum inhibitory concentration ratio as a predictor of vancomycin treatment outcome in methicillin-resistant Staphylococcus aureus bacteraemia.
Jung Y; Song KH; Cho Je; Kim HS; Kim NH; Kim TS; Choe PG; Chung JY; Park WB; Bang JH; Kim ES; Park KU; Park SW; Kim HB; Kim NJ; Oh MD
Int J Antimicrob Agents; 2014 Feb; 43(2):179-83. PubMed ID: 24315788
[TBL] [Abstract][Full Text] [Related]
36. Acute kidney injury during daptomycin versus vancomycin treatment in cardiovascular critically ill patients: a propensity score matched analysis.
Gaudard P; Saour M; Morquin D; David H; Eliet J; Villiet M; Daures JP; Colson P
BMC Infect Dis; 2019 May; 19(1):438. PubMed ID: 31109283
[TBL] [Abstract][Full Text] [Related]
37. Optimizing Vancomycin Use Through 2-Point AUC-Based Therapeutic Drug Monitoring in Pediatric Patients.
Suchartlikitwong P; Anugulruengkitt S; Wacharachaisurapol N; Jantarabenjakul W; Sophonphan J; Theerawit T; Chatsuwan T; Wattanavijitkul T; Puthanakit T
J Clin Pharmacol; 2019 Dec; 59(12):1597-1605. PubMed ID: 31342543
[TBL] [Abstract][Full Text] [Related]
38. Vancomycin-induced acute kidney injury in elderly Chinese patients: a single-centre cross-sectional study.
Pan KM; Wu Y; Chen C; Chen ZZ; Xu JA; Cao L; Xu Q; Wu W; Dai PF; Li XY; Lv QZ
Br J Clin Pharmacol; 2018 Aug; 84(8):1706-1718. PubMed ID: 29607531
[TBL] [Abstract][Full Text] [Related]
39. Current recommended dosing of vancomycin for children with invasive methicillin-resistant Staphylococcus aureus infections is inadequate.
Frymoyer A; Hersh AL; Benet LZ; Guglielmo BJ
Pediatr Infect Dis J; 2009 May; 28(5):398-402. PubMed ID: 19295465
[TBL] [Abstract][Full Text] [Related]
40. Clinical and Pharmacokinetic Outcomes of Peak-Trough-Based Versus Trough-Based Vancomycin Therapeutic Drug Monitoring Approaches: A Pragmatic Randomized Controlled Trial.
Al-Sulaiti FK; Nader AM; Saad MO; Shaukat A; Parakadavathu R; Elzubair A; Al-Badriyeh D; Elewa H; Awaisu A
Eur J Drug Metab Pharmacokinet; 2019 Oct; 44(5):639-652. PubMed ID: 30919233
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
